Loading…

Chromosomal microarray in fetuses with increased nuchal translucency

ABSTRACT Objective To assess the clinical value of using high‐resolution chromosomal microarray (CMA) for the examination of genomic imbalances in prenatal uncultured chorionic villus samples from fetuses with increased nuchal translucency (NT) and a normal quantitative fluorescent polymerase chain...

Full description

Saved in:
Bibliographic Details
Published in:Ultrasound in obstetrics & gynecology 2015-01, Vol.45 (1), p.95-100
Main Authors: Lund, I. C. B., Christensen, R., Petersen, O. B., Vogel, I., Vestergaard, E. M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3
cites cdi_FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3
container_end_page 100
container_issue 1
container_start_page 95
container_title Ultrasound in obstetrics & gynecology
container_volume 45
creator Lund, I. C. B.
Christensen, R.
Petersen, O. B.
Vogel, I.
Vestergaard, E. M.
description ABSTRACT Objective To assess the clinical value of using high‐resolution chromosomal microarray (CMA) for the examination of genomic imbalances in prenatal uncultured chorionic villus samples from fetuses with increased nuchal translucency (NT) and a normal quantitative fluorescent polymerase chain reaction (QF‐PCR) result, in a clinical setting in which more than 95% of pregnant women receive first‐trimester combined screening. Methods From January 2013 to July 2014, we included 132 chorionic villus samples from consecutive ongoing pregnancies, with fetal NT ≥ 3.5  mm at 11–13 weeks' gestation, from obstetric units (publicly funded healthcare) in Central and North Denmark Regions. DNA was extracted directly from the samples and examined with QF‐PCR (n = 132) and 180 kb oligonucleotide array‐based comparative genomic hybridization (n =  94). Results In 38 cases, aneuploidies for chromosomes 18, 21 or X, or triploidy, were detected by QF‐PCR. Among the 94 cases with a normal QF‐PCR result, we detected pathogenic copy number variants (CNVs) by CMA in 12 fetuses (12.8% (95% CI, 7.5–21.0%)). In an additional three (3.2%) cases, CNVs with uncertain clinical significance were detected. Conclusion CMA is a valuable diagnostic technique in pregnancies with isolated fetal NT ≥ 3.5 mm. Copyright © 2014 ISUOG. Published by John Wiley & Sons Ltd.
doi_str_mv 10.1002/uog.14726
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1647016180</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1647016180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3</originalsourceid><addsrcrecordid>eNqN0U9LwzAYBvAgipvTg19ACl700O1N0yTNUeZfGOziziGmqetom5m0jH57Mzs9CIKnvIEfD8n7IHSJYYoBklln36c45Qk7QmOcMhEDB3qMxiAYxJyJZITOvN8AAEsJO0WjhBJBEgxjdD9fO1tbb2tVRXWpnVXOqT4qm6gwbeeNj3Zluw537YzyJo-aTq-DbZ1qfNVp0-j-HJ0UqvLm4nBO0Orx4XX-HC-WTy_zu0Ws0wSzWHOqgEICjFAlssyQlOdKURHeKTJhNAHOKC5wnlFKszBmgqaCZ6CE5saQCboZcrfOfnTGt7IuvTZVpRpjOy8xSzlghjP4D00Yxpjv6fUvurGda8JH9goTIcKOg7odVFiR984UcuvKWrleYpD7FmRoQX61EOzVIbF7q03-I7_XHsBsALuyMv3fSXK1fBoiPwEqhY4-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1641399002</pqid></control><display><type>article</type><title>Chromosomal microarray in fetuses with increased nuchal translucency</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Lund, I. C. B. ; Christensen, R. ; Petersen, O. B. ; Vogel, I. ; Vestergaard, E. M.</creator><creatorcontrib>Lund, I. C. B. ; Christensen, R. ; Petersen, O. B. ; Vogel, I. ; Vestergaard, E. M.</creatorcontrib><description>ABSTRACT Objective To assess the clinical value of using high‐resolution chromosomal microarray (CMA) for the examination of genomic imbalances in prenatal uncultured chorionic villus samples from fetuses with increased nuchal translucency (NT) and a normal quantitative fluorescent polymerase chain reaction (QF‐PCR) result, in a clinical setting in which more than 95% of pregnant women receive first‐trimester combined screening. Methods From January 2013 to July 2014, we included 132 chorionic villus samples from consecutive ongoing pregnancies, with fetal NT ≥ 3.5  mm at 11–13 weeks' gestation, from obstetric units (publicly funded healthcare) in Central and North Denmark Regions. DNA was extracted directly from the samples and examined with QF‐PCR (n = 132) and 180 kb oligonucleotide array‐based comparative genomic hybridization (n =  94). Results In 38 cases, aneuploidies for chromosomes 18, 21 or X, or triploidy, were detected by QF‐PCR. Among the 94 cases with a normal QF‐PCR result, we detected pathogenic copy number variants (CNVs) by CMA in 12 fetuses (12.8% (95% CI, 7.5–21.0%)). In an additional three (3.2%) cases, CNVs with uncertain clinical significance were detected. Conclusion CMA is a valuable diagnostic technique in pregnancies with isolated fetal NT ≥ 3.5 mm. Copyright © 2014 ISUOG. Published by John Wiley &amp; Sons Ltd.</description><identifier>ISSN: 0960-7692</identifier><identifier>EISSN: 1469-0705</identifier><identifier>DOI: 10.1002/uog.14726</identifier><identifier>PMID: 25393210</identifier><identifier>CODEN: UOGYFJ</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>array comparative genomic hybridization ; chromosomal microarray ; Chromosomes ; Down syndrome ; Down Syndrome - diagnosis ; Down Syndrome - embryology ; Down Syndrome - genetics ; Female ; Fetuses ; genomic imbalance ; Humans ; nuchal translucency ; Nuchal Translucency Measurement - methods ; Polymerase Chain Reaction ; Pregnancy ; Pregnancy Trimester, First ; Pregnancy, High-Risk ; prenatal diagnosis ; Prenatal Diagnosis - methods ; Prospective Studies ; Reproducibility of Results</subject><ispartof>Ultrasound in obstetrics &amp; gynecology, 2015-01, Vol.45 (1), p.95-100</ispartof><rights>Copyright © 2014 ISUOG. Published by John Wiley &amp; Sons Ltd</rights><rights>Copyright © 2014 ISUOG. Published by John Wiley &amp; Sons Ltd.</rights><rights>Copyright © 2015 ISUOG. Published by John Wiley &amp; Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3</citedby><cites>FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25393210$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lund, I. C. B.</creatorcontrib><creatorcontrib>Christensen, R.</creatorcontrib><creatorcontrib>Petersen, O. B.</creatorcontrib><creatorcontrib>Vogel, I.</creatorcontrib><creatorcontrib>Vestergaard, E. M.</creatorcontrib><title>Chromosomal microarray in fetuses with increased nuchal translucency</title><title>Ultrasound in obstetrics &amp; gynecology</title><addtitle>Ultrasound Obstet Gynecol</addtitle><description>ABSTRACT Objective To assess the clinical value of using high‐resolution chromosomal microarray (CMA) for the examination of genomic imbalances in prenatal uncultured chorionic villus samples from fetuses with increased nuchal translucency (NT) and a normal quantitative fluorescent polymerase chain reaction (QF‐PCR) result, in a clinical setting in which more than 95% of pregnant women receive first‐trimester combined screening. Methods From January 2013 to July 2014, we included 132 chorionic villus samples from consecutive ongoing pregnancies, with fetal NT ≥ 3.5  mm at 11–13 weeks' gestation, from obstetric units (publicly funded healthcare) in Central and North Denmark Regions. DNA was extracted directly from the samples and examined with QF‐PCR (n = 132) and 180 kb oligonucleotide array‐based comparative genomic hybridization (n =  94). Results In 38 cases, aneuploidies for chromosomes 18, 21 or X, or triploidy, were detected by QF‐PCR. Among the 94 cases with a normal QF‐PCR result, we detected pathogenic copy number variants (CNVs) by CMA in 12 fetuses (12.8% (95% CI, 7.5–21.0%)). In an additional three (3.2%) cases, CNVs with uncertain clinical significance were detected. Conclusion CMA is a valuable diagnostic technique in pregnancies with isolated fetal NT ≥ 3.5 mm. Copyright © 2014 ISUOG. Published by John Wiley &amp; Sons Ltd.</description><subject>array comparative genomic hybridization</subject><subject>chromosomal microarray</subject><subject>Chromosomes</subject><subject>Down syndrome</subject><subject>Down Syndrome - diagnosis</subject><subject>Down Syndrome - embryology</subject><subject>Down Syndrome - genetics</subject><subject>Female</subject><subject>Fetuses</subject><subject>genomic imbalance</subject><subject>Humans</subject><subject>nuchal translucency</subject><subject>Nuchal Translucency Measurement - methods</subject><subject>Polymerase Chain Reaction</subject><subject>Pregnancy</subject><subject>Pregnancy Trimester, First</subject><subject>Pregnancy, High-Risk</subject><subject>prenatal diagnosis</subject><subject>Prenatal Diagnosis - methods</subject><subject>Prospective Studies</subject><subject>Reproducibility of Results</subject><issn>0960-7692</issn><issn>1469-0705</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqN0U9LwzAYBvAgipvTg19ACl700O1N0yTNUeZfGOziziGmqetom5m0jH57Mzs9CIKnvIEfD8n7IHSJYYoBklln36c45Qk7QmOcMhEDB3qMxiAYxJyJZITOvN8AAEsJO0WjhBJBEgxjdD9fO1tbb2tVRXWpnVXOqT4qm6gwbeeNj3Zluw537YzyJo-aTq-DbZ1qfNVp0-j-HJ0UqvLm4nBO0Orx4XX-HC-WTy_zu0Ws0wSzWHOqgEICjFAlssyQlOdKURHeKTJhNAHOKC5wnlFKszBmgqaCZ6CE5saQCboZcrfOfnTGt7IuvTZVpRpjOy8xSzlghjP4D00Yxpjv6fUvurGda8JH9goTIcKOg7odVFiR984UcuvKWrleYpD7FmRoQX61EOzVIbF7q03-I7_XHsBsALuyMv3fSXK1fBoiPwEqhY4-</recordid><startdate>201501</startdate><enddate>201501</enddate><creator>Lund, I. C. B.</creator><creator>Christensen, R.</creator><creator>Petersen, O. B.</creator><creator>Vogel, I.</creator><creator>Vestergaard, E. M.</creator><general>John Wiley &amp; Sons, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><scope>RC3</scope></search><sort><creationdate>201501</creationdate><title>Chromosomal microarray in fetuses with increased nuchal translucency</title><author>Lund, I. C. B. ; Christensen, R. ; Petersen, O. B. ; Vogel, I. ; Vestergaard, E. M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>array comparative genomic hybridization</topic><topic>chromosomal microarray</topic><topic>Chromosomes</topic><topic>Down syndrome</topic><topic>Down Syndrome - diagnosis</topic><topic>Down Syndrome - embryology</topic><topic>Down Syndrome - genetics</topic><topic>Female</topic><topic>Fetuses</topic><topic>genomic imbalance</topic><topic>Humans</topic><topic>nuchal translucency</topic><topic>Nuchal Translucency Measurement - methods</topic><topic>Polymerase Chain Reaction</topic><topic>Pregnancy</topic><topic>Pregnancy Trimester, First</topic><topic>Pregnancy, High-Risk</topic><topic>prenatal diagnosis</topic><topic>Prenatal Diagnosis - methods</topic><topic>Prospective Studies</topic><topic>Reproducibility of Results</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lund, I. C. B.</creatorcontrib><creatorcontrib>Christensen, R.</creatorcontrib><creatorcontrib>Petersen, O. B.</creatorcontrib><creatorcontrib>Vogel, I.</creatorcontrib><creatorcontrib>Vestergaard, E. M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Genetics Abstracts</collection><jtitle>Ultrasound in obstetrics &amp; gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lund, I. C. B.</au><au>Christensen, R.</au><au>Petersen, O. B.</au><au>Vogel, I.</au><au>Vestergaard, E. M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chromosomal microarray in fetuses with increased nuchal translucency</atitle><jtitle>Ultrasound in obstetrics &amp; gynecology</jtitle><addtitle>Ultrasound Obstet Gynecol</addtitle><date>2015-01</date><risdate>2015</risdate><volume>45</volume><issue>1</issue><spage>95</spage><epage>100</epage><pages>95-100</pages><issn>0960-7692</issn><eissn>1469-0705</eissn><coden>UOGYFJ</coden><abstract>ABSTRACT Objective To assess the clinical value of using high‐resolution chromosomal microarray (CMA) for the examination of genomic imbalances in prenatal uncultured chorionic villus samples from fetuses with increased nuchal translucency (NT) and a normal quantitative fluorescent polymerase chain reaction (QF‐PCR) result, in a clinical setting in which more than 95% of pregnant women receive first‐trimester combined screening. Methods From January 2013 to July 2014, we included 132 chorionic villus samples from consecutive ongoing pregnancies, with fetal NT ≥ 3.5  mm at 11–13 weeks' gestation, from obstetric units (publicly funded healthcare) in Central and North Denmark Regions. DNA was extracted directly from the samples and examined with QF‐PCR (n = 132) and 180 kb oligonucleotide array‐based comparative genomic hybridization (n =  94). Results In 38 cases, aneuploidies for chromosomes 18, 21 or X, or triploidy, were detected by QF‐PCR. Among the 94 cases with a normal QF‐PCR result, we detected pathogenic copy number variants (CNVs) by CMA in 12 fetuses (12.8% (95% CI, 7.5–21.0%)). In an additional three (3.2%) cases, CNVs with uncertain clinical significance were detected. Conclusion CMA is a valuable diagnostic technique in pregnancies with isolated fetal NT ≥ 3.5 mm. Copyright © 2014 ISUOG. Published by John Wiley &amp; Sons Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>25393210</pmid><doi>10.1002/uog.14726</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0960-7692
ispartof Ultrasound in obstetrics & gynecology, 2015-01, Vol.45 (1), p.95-100
issn 0960-7692
1469-0705
language eng
recordid cdi_proquest_miscellaneous_1647016180
source Wiley-Blackwell Read & Publish Collection
subjects array comparative genomic hybridization
chromosomal microarray
Chromosomes
Down syndrome
Down Syndrome - diagnosis
Down Syndrome - embryology
Down Syndrome - genetics
Female
Fetuses
genomic imbalance
Humans
nuchal translucency
Nuchal Translucency Measurement - methods
Polymerase Chain Reaction
Pregnancy
Pregnancy Trimester, First
Pregnancy, High-Risk
prenatal diagnosis
Prenatal Diagnosis - methods
Prospective Studies
Reproducibility of Results
title Chromosomal microarray in fetuses with increased nuchal translucency
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T04%3A55%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chromosomal%20microarray%20in%20fetuses%20with%20increased%20nuchal%20translucency&rft.jtitle=Ultrasound%20in%20obstetrics%20&%20gynecology&rft.au=Lund,%20I.%20C.%20B.&rft.date=2015-01&rft.volume=45&rft.issue=1&rft.spage=95&rft.epage=100&rft.pages=95-100&rft.issn=0960-7692&rft.eissn=1469-0705&rft.coden=UOGYFJ&rft_id=info:doi/10.1002/uog.14726&rft_dat=%3Cproquest_cross%3E1647016180%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4216-c75a05020635a988e347daa59096989ec307651f1d8555865189549780a9c7ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1641399002&rft_id=info:pmid/25393210&rfr_iscdi=true